FDA Adverse Event Malfunction Summary report: N

ARCHITECT C16000

MDR report key: 14190073 · Received April 22, 2022

Report

Report Number
3016438761-2022-00173
Event Type
Malfunction
Date Received
April 22, 2022
Date of Event
March 14, 2022
Report Date
May 4, 2022
Manufacturer
ABBOTT LABORATORIES
Product Code
JJE
UDI-DI
00380740005924
PMA / PMN Number
EXEMPT
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NO
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

(B)(6). AN EVALUATION IS IN PROCESS. A FOLLOW-UP REPORT WILL BE SUBMITTED WHEN THE EVALUATION IS COMPLETE.

Additional Manufacturer Narrative · 0

THE FIELD SERVICE REPRESENTATIVE (FSR) INSPECTED THE INSTRUMENT AND RESOLVED THE ISSUE BY REPLACING THE ASPIRATE AND DISPENSE TUBING TO THE HIGH CONCENTRATION WASTE NOZZLE A (TBG. H.C. NOZZLE A WASTE (ROHS) AND TBG, H.C. NOZZLE A (ROHS)). NO ADDITIONAL DISCREPANT RESULT ISSUES HAVE BEEN REPORTED SINCE THE PARTS WERE REPLACED. THE INSTRUMENT SERVICE HISTORY REVIEW REVEALED TWO (2) ADDITIONAL SERVICE TICKETS THAT MAY BE RELATED TO THE CURRENT COMPLAINT. TRENDING REVIEW DID NOT IDENTIFY ANY TRENDS OR SYSTEMIC ISSUES FOR THE INSTRUMENT PARTS. A REVIEW OF THE PRODUCT MONITORING REVIEW FOR CLINICAL CHEMISTRY SYSTEMS DID NOT IDENTIFY ANY SIMILAR ISSUES RELATED TO THE ARCHITECT SYSTEM, LIKELY CAUSE PARTS, OR DISCREPANT RESULTS AS DESCRIBED IN THIS TICKET. THE ARCHITECT C4000, C8000, AND THE C16000 ERRATIC RESULT RATES WERE WITHIN ACCEPTABLE LIMITS WITH NO TRENDS IDENTIFIED. A REVIEW OF HISTORICAL DATA DID NOT IDENTIFY ANY NON-CONFORMANCES OR POTENTIAL NON-CONFORMANCES RELATED TO THE PARTS ASSOCIATED WITH THE COMPLAINT. LABELING WAS REVIEWED AND ADEQUATELY ADDRESSES THE ISSUE UNDER REVIEW. BASED ON THE INVESTIGATION, NO SYSTEMIC ISSUE OR DEFICIENCY OF THE ARCHITECT C16000, SERIAL NUMBER (B)(6), WAS IDENTIFIED.

Description of Event or Problem · 0

THE CUSTOMER FOUND A LEAKAGE ON THE ARCHITECT C16000 PROCESSING MODULE THAT CAUSED THE TEST TO BE DILUTED DURING SAMPLE PROCESSING. THE CUSTOMER REPLACED 7-203008-01 TBG, HC NOZZLE A AND THEN 7-203008-02 TBG HC NOZZLE A. THE CUSTOMER RAN CONTROLS AND CHECKED THE LAST RELEASED RESULTS. EVERYTHING LOOKED OK, BUT THE CUSTOMER STATED THE DOCTOR HAD QUESTIONED PATIENT RESULTS SINCE THEY WERE NOT CONSISTENT WITH PATIENT HISTORY. THE CUSTOMER PROVIDED FALSELY ELEVATED CREATININE RESULTS FOR ONE PATIENT. SID (B)(6), (B)(6) 2022: CREAENZ = 579 UMOL/L, REPEAT ON (B)(6) 2022: CREAENZ = 50 UMOL/L. NO IMPACT TO PATIENT MANAGEMENT WAS REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
171223 ARCHITECT C16000 ANALYZER, CHEMISTRY (PHOTOMETRIC, DISCRETE), FOR CLINICAL USE JJE ABBOTT LABORATORIES 3L77-01 00380740005924

Patients

Seq Age Sex Outcome Treatment
1 Unknown CREATININE, UNKNOWN LIST AND LOT NUMBER| CREATININE, UNKNOWN LIST AND LOT NUMBER